Letter by Vilke et al Regarding Article, “Sudden Cardiac Arrest and Death Following Application of Shocks From a TASER Electronic Control Device”
Authors: Gary M. Vilke, Theodore C. Chan, Steven Karch
Journal: Circulation (2013)

We read with interest the article by Zipes on TASERs 1 that has received lay press coverage, with many news headlines and internet blogs reporting, perhaps erroneously, that the study's findings reflect the position of the American Heart Association.This article describes 8 cases to support an opinion that TASERs can cause cardiac dysrhythmias and sudden death.However, we disagree with this conclusion, because there are a number of details of the cases that require further discussion.The Methods section states all subjects "were previously clinically healthy males;" however, criteria for "clinically healthy" were not defined.In fact, the table shows that all but one had a significantly enlarged heart or evidence of actual heart disease.When the reported heart weights were compared with the Mayo Clinic nomogram compiled by Kitzman et al, 2 it was evident that all but patient No. 3 had mean heart weights greater than the predicted mean.Subject No. 2, who was 17 years of age and weighed 80 kg, had a heart weight of 410 g (versus 327 g, or 120% of predicted) in addition to focal atherosclerosis evident at autopsy.Subject No. 4, who was 24 years of age and who also weighed 80 kg, had a 400-g heart (versus 327 g, or 120% of predicted) and possible myocarditis.The heart of subject No. 5, a 100-kg man, weighed 470 g (versus 336 g, or 129% of predicted, whereas subject No. 8, a 79-kg man, had a 400 g heart (versus 325 g or 119% of predicted).As Dr Zipes has previously observed himself, left ventricular hypertrophy is clearly a risk factor for sudden cardiac death. 3ecause of involvement in litigation related to some of these cases, 2 of the authors of this letter have personally reviewed original copies of the medical examiner reports, medical charts, and other documents in a manner similar to Dr Zipes, and one of us reviewed the cardiac histology.We are aware of additional details for these cases that were omitted, which provide greater context.Subject No. 1 had a history of chronic alcoholism, illicit drug use, and mental illness and had a prolonged QTc documented on the day of his TASER activation.Similarly, subject No. 5 had known epilepsy, experienced a seizure, and was in a combative postictal state immediately before and during the time of TASER activation.Dr Zipes also reports that, in all of the cases, subjects received shocks "with one or both barbs in the anterior chest near or over the heart," but never provided specifics on probe location nor differentiates between probe and drive stun deployments.In subject No. 5, the table reports "13 shocks totaling 62 seconds in <3 minutes."Based on his reporting, the reader would conclude that he received 62 seconds of activations "over the heart."However, the reality is that he only received the initial activations in probe mode with the majority actually in drive stun mode to the leg.Dr Zipes opines that various experimental studies support his conclusion that the TASER can cause cardiac capture and induce ventricular fibrillation or ventricular tachycardia in humans.The author